Gengqing Song

Appearances

GLUCAGON-LIKE PROTEIN-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH AN INCREASED RISK OF DEVELOPING CHOLECYSTITIS BUT NOT ACUTE OR CHRONIC PANCREATITIS: RESULTS FROM A GLOBAL HEALTHCARE DATABASE
Date
May 7, 2023
It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…
Presenter
Benjamin Liu
Speakers
Samantha Mathialagan
Katherine Liang
Yasir Tarabichi
Gengqing Song
ORAL CONTRACEPTIVES AND HORMONE REPLACEMENT THERAPY ARE ASSOCIATED WITH HIGHER RISKS OF DEVELOPING UPPER GASTROINTESTINAL DISORDERS
Date
May 9, 2023
INTRODUCTION: Patients with upper gastrointestinal (UGI) symptoms of abdominal pain, nausea, vomiting, and bloating often complain within the postprandial period…
Presenter
Yuhan Fu
Speaker
Gengqing Song
RE-EXAMINING THE RISKS OF GASTROINTESTINAL ADVERSE EVENTS ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR WEIGHT LOSS WITH MORE STRINGENT CRITERIA ON A COMPREHENSIVE LARGE DATABASE.
Date
May 21, 2024
Sodhi et al. (2023) recently reported that glucagon-like peptide-1 receptor agonists (GLP-1 RA) usage for weight loss was associated with increased risks of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease when compared to bupropion-naltrexone (BN)…
Presenter
Benjamin Liu
Speaker
Gengqing Song